nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—liver cancer	0.717	1	CbGaD
Albendazole—CYP1A2—Sorafenib—liver cancer	0.035	0.308	CbGbCtD
Albendazole—ABCB1—Sorafenib—liver cancer	0.0306	0.269	CbGbCtD
Albendazole—ABCB1—Doxorubicin—liver cancer	0.0186	0.163	CbGbCtD
Albendazole—CYP3A4—Sorafenib—liver cancer	0.0183	0.161	CbGbCtD
Albendazole—CYP3A4—Doxorubicin—liver cancer	0.0111	0.0979	CbGbCtD
Albendazole—Alopecia reversible—Epirubicin—liver cancer	0.00348	0.077	CcSEcCtD
Albendazole—Alopecia reversible—Doxorubicin—liver cancer	0.00322	0.0712	CcSEcCtD
Albendazole—Mebendazole—CYP1A1—liver cancer	0.00265	1	CrCbGaD
Albendazole—Renal failure acute—Sorafenib—liver cancer	0.00168	0.0372	CcSEcCtD
Albendazole—Neutropenia—Sorafenib—liver cancer	0.00125	0.0277	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00118	0.0262	CcSEcCtD
Albendazole—Hepatobiliary disease—Sorafenib—liver cancer	0.00113	0.025	CcSEcCtD
Albendazole—Urinary tract disorder—Sorafenib—liver cancer	0.00106	0.0234	CcSEcCtD
Albendazole—Urethral disorder—Sorafenib—liver cancer	0.00105	0.0233	CcSEcCtD
Albendazole—Erythema multiforme—Sorafenib—liver cancer	0.00101	0.0224	CcSEcCtD
Albendazole—Immune system disorder—Sorafenib—liver cancer	0.000969	0.0214	CcSEcCtD
Albendazole—Alopecia—Sorafenib—liver cancer	0.000948	0.021	CcSEcCtD
Albendazole—Leukopenia—Sorafenib—liver cancer	0.000836	0.0185	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00079	0.0175	CcSEcCtD
Albendazole—Thrombocytopenia—Sorafenib—liver cancer	0.000746	0.0165	CcSEcCtD
Albendazole—Aplastic anaemia—Epirubicin—liver cancer	0.000741	0.0164	CcSEcCtD
Albendazole—Skin disorder—Sorafenib—liver cancer	0.00074	0.0164	CcSEcCtD
Albendazole—Aplastic anaemia—Doxorubicin—liver cancer	0.000686	0.0152	CcSEcCtD
Albendazole—Gastrointestinal pain—Sorafenib—liver cancer	0.000623	0.0138	CcSEcCtD
Albendazole—Renal failure acute—Epirubicin—liver cancer	0.000621	0.0137	CcSEcCtD
Albendazole—Urticaria—Sorafenib—liver cancer	0.000606	0.0134	CcSEcCtD
Albendazole—Abdominal pain—Sorafenib—liver cancer	0.000603	0.0133	CcSEcCtD
Albendazole—Body temperature increased—Sorafenib—liver cancer	0.000603	0.0133	CcSEcCtD
Albendazole—Renal failure acute—Doxorubicin—liver cancer	0.000574	0.0127	CcSEcCtD
Albendazole—Hypersensitivity—Sorafenib—liver cancer	0.000562	0.0124	CcSEcCtD
Albendazole—Liver function test abnormal—Epirubicin—liver cancer	0.000529	0.0117	CcSEcCtD
Albendazole—Dizziness—Sorafenib—liver cancer	0.000504	0.0112	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—liver cancer	0.00049	0.0108	CcSEcCtD
Albendazole—Vomiting—Sorafenib—liver cancer	0.000485	0.0107	CcSEcCtD
Albendazole—Rash—Sorafenib—liver cancer	0.000481	0.0106	CcSEcCtD
Albendazole—Dermatitis—Sorafenib—liver cancer	0.00048	0.0106	CcSEcCtD
Albendazole—Headache—Sorafenib—liver cancer	0.000478	0.0106	CcSEcCtD
Albendazole—Pancytopenia—Epirubicin—liver cancer	0.00047	0.0104	CcSEcCtD
Albendazole—Neutropenia—Epirubicin—liver cancer	0.000463	0.0102	CcSEcCtD
Albendazole—Nausea—Sorafenib—liver cancer	0.000453	0.01	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000438	0.00969	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—liver cancer	0.000435	0.00963	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—liver cancer	0.000429	0.00948	CcSEcCtD
Albendazole—Hepatobiliary disease—Epirubicin—liver cancer	0.000418	0.00924	CcSEcCtD
Albendazole—Agranulocytosis—Epirubicin—liver cancer	0.000412	0.00912	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000405	0.00897	CcSEcCtD
Albendazole—Hepatitis—Epirubicin—liver cancer	0.000397	0.00877	CcSEcCtD
Albendazole—Urinary tract disorder—Epirubicin—liver cancer	0.000392	0.00866	CcSEcCtD
Albendazole—Urethral disorder—Epirubicin—liver cancer	0.000389	0.0086	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000387	0.00855	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—liver cancer	0.000381	0.00844	CcSEcCtD
Albendazole—Erythema multiforme—Epirubicin—liver cancer	0.000375	0.0083	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—liver cancer	0.000367	0.00812	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—liver cancer	0.000362	0.00802	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—liver cancer	0.00036	0.00796	CcSEcCtD
Albendazole—Immune system disorder—Epirubicin—liver cancer	0.000358	0.00792	CcSEcCtD
Albendazole—Alopecia—Epirubicin—liver cancer	0.00035	0.00775	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—liver cancer	0.000347	0.00768	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—liver cancer	0.000331	0.00733	CcSEcCtD
Albendazole—Alopecia—Doxorubicin—liver cancer	0.000324	0.00717	CcSEcCtD
Albendazole—Vertigo—Epirubicin—liver cancer	0.00031	0.00686	CcSEcCtD
Albendazole—Leukopenia—Epirubicin—liver cancer	0.000309	0.00684	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000292	0.00646	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—liver cancer	0.000287	0.00635	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—liver cancer	0.000286	0.00633	CcSEcCtD
Albendazole—Thrombocytopenia—Epirubicin—liver cancer	0.000276	0.0061	CcSEcCtD
Albendazole—Skin disorder—Epirubicin—liver cancer	0.000274	0.00605	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00027	0.00597	CcSEcCtD
Albendazole—Thrombocytopenia—Doxorubicin—liver cancer	0.000255	0.00565	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—liver cancer	0.000253	0.0056	CcSEcCtD
Albendazole—Gastrointestinal pain—Epirubicin—liver cancer	0.00023	0.0051	CcSEcCtD
Albendazole—Urticaria—Epirubicin—liver cancer	0.000224	0.00495	CcSEcCtD
Albendazole—Abdominal pain—Epirubicin—liver cancer	0.000223	0.00493	CcSEcCtD
Albendazole—Body temperature increased—Epirubicin—liver cancer	0.000223	0.00493	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—liver cancer	0.000213	0.00472	CcSEcCtD
Albendazole—Hypersensitivity—Epirubicin—liver cancer	0.000208	0.00459	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—liver cancer	0.000207	0.00458	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—liver cancer	0.000206	0.00456	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—liver cancer	0.000206	0.00456	CcSEcCtD
Albendazole—Hypersensitivity—Doxorubicin—liver cancer	0.000192	0.00425	CcSEcCtD
Albendazole—Dizziness—Epirubicin—liver cancer	0.000186	0.00412	CcSEcCtD
Albendazole—Vomiting—Epirubicin—liver cancer	0.000179	0.00396	CcSEcCtD
Albendazole—Rash—Epirubicin—liver cancer	0.000178	0.00393	CcSEcCtD
Albendazole—Dermatitis—Epirubicin—liver cancer	0.000177	0.00393	CcSEcCtD
Albendazole—Headache—Epirubicin—liver cancer	0.000176	0.0039	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—liver cancer	0.000172	0.00381	CcSEcCtD
Albendazole—Nausea—Epirubicin—liver cancer	0.000167	0.0037	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—liver cancer	0.000166	0.00367	CcSEcCtD
Albendazole—Rash—Doxorubicin—liver cancer	0.000164	0.00364	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—liver cancer	0.000164	0.00363	CcSEcCtD
Albendazole—Headache—Doxorubicin—liver cancer	0.000163	0.00361	CcSEcCtD
Albendazole—Nausea—Doxorubicin—liver cancer	0.000155	0.00343	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—CCND1—liver cancer	9.25e-05	0.000763	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	9.2e-05	0.000759	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	9.15e-05	0.000755	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN1A—liver cancer	8.94e-05	0.000738	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP2E1—liver cancer	8.81e-05	0.000727	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—liver cancer	8.76e-05	0.000722	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	8.75e-05	0.000722	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—PPARA—liver cancer	8.72e-05	0.000719	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	8.69e-05	0.000717	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	8.56e-05	0.000706	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	8.52e-05	0.000703	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—HPGDS—liver cancer	8.34e-05	0.000688	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MYC—liver cancer	8.29e-05	0.000684	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	8.18e-05	0.000675	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	8.16e-05	0.000673	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—CASP3—liver cancer	8.16e-05	0.000673	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL2—liver cancer	8.15e-05	0.000672	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GGT1—liver cancer	8.09e-05	0.000667	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	7.99e-05	0.000659	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	7.84e-05	0.000646	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	7.83e-05	0.000645	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	7.83e-05	0.000645	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	7.82e-05	0.000645	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CTNNB1—liver cancer	7.63e-05	0.000629	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7.45e-05	0.000614	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—UGDH—liver cancer	7.43e-05	0.000613	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MYC—liver cancer	7.42e-05	0.000612	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	7.4e-05	0.00061	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—liver cancer	7.39e-05	0.00061	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	7.3e-05	0.000602	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	7.3e-05	0.000602	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTP1—liver cancer	7.27e-05	0.000599	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	7.24e-05	0.000597	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—liver cancer	7.24e-05	0.000597	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	7.17e-05	0.000591	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—F2—liver cancer	7.09e-05	0.000585	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	7.02e-05	0.000579	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—EPT1—liver cancer	6.98e-05	0.000576	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—liver cancer	6.92e-05	0.000571	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.8e-05	0.000561	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.71e-05	0.000553	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTM1—liver cancer	6.68e-05	0.000551	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TAT—liver cancer	6.62e-05	0.000546	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—liver cancer	6.61e-05	0.000545	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	6.59e-05	0.000543	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—liver cancer	6.54e-05	0.00054	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.51e-05	0.000537	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ALB—liver cancer	6.48e-05	0.000534	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	6.44e-05	0.000531	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TGFB1—liver cancer	6.35e-05	0.000524	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1A1—liver cancer	6.33e-05	0.000522	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GGT1—liver cancer	6.25e-05	0.000515	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	6.25e-05	0.000515	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—liver cancer	6.24e-05	0.000515	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	6.21e-05	0.000512	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	6.16e-05	0.000508	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	6.16e-05	0.000508	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—liver cancer	6.09e-05	0.000502	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	6.04e-05	0.000498	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—liver cancer	6.04e-05	0.000498	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP2—liver cancer	6.01e-05	0.000496	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—liver cancer	5.93e-05	0.000489	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—UGDH—liver cancer	5.93e-05	0.000489	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—RAF1—liver cancer	5.86e-05	0.000483	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN1B—liver cancer	5.85e-05	0.000483	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	5.71e-05	0.000471	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.61e-05	0.000463	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND1—liver cancer	5.58e-05	0.00046	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—EPT1—liver cancer	5.58e-05	0.00046	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.53e-05	0.000456	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN1A—liver cancer	5.4e-05	0.000445	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TAT—liver cancer	5.29e-05	0.000436	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.15e-05	0.000425	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.1e-05	0.000421	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.08e-05	0.000419	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—liver cancer	5.01e-05	0.000413	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.89e-05	0.000403	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.87e-05	0.000402	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.82e-05	0.000398	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.75e-05	0.000392	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UGDH—liver cancer	4.74e-05	0.000391	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CTNNB1—liver cancer	4.61e-05	0.00038	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CPT1B—liver cancer	4.5e-05	0.000371	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GLUL—liver cancer	4.5e-05	0.000371	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	4.48e-05	0.00037	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—liver cancer	4.48e-05	0.000369	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—EPT1—liver cancer	4.45e-05	0.000367	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NR1H4—liver cancer	4.34e-05	0.000358	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA3—liver cancer	4.27e-05	0.000352	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TAT—liver cancer	4.22e-05	0.000348	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.15e-05	0.000342	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.11e-05	0.000339	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.03e-05	0.000332	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	3.92e-05	0.000323	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.91e-05	0.000323	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA4—liver cancer	3.9e-05	0.000322	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.88e-05	0.00032	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA2—liver cancer	3.8e-05	0.000314	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.79e-05	0.000313	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.77e-05	0.000311	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.7e-05	0.000305	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—liver cancer	3.68e-05	0.000303	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTA1—liver cancer	3.67e-05	0.000303	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UGDH—liver cancer	3.65e-05	0.000301	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NAT2—liver cancer	3.63e-05	0.000299	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CPT1B—liver cancer	3.59e-05	0.000296	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GLUL—liver cancer	3.59e-05	0.000296	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.49e-05	0.000288	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALDOB—liver cancer	3.48e-05	0.000287	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NR1H4—liver cancer	3.47e-05	0.000286	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—EPT1—liver cancer	3.44e-05	0.000283	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.42e-05	0.000282	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA3—liver cancer	3.41e-05	0.000281	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CRABP1—liver cancer	3.32e-05	0.000274	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.28e-05	0.00027	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TAT—liver cancer	3.26e-05	0.000269	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.14e-05	0.000259	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.14e-05	0.000259	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA4—liver cancer	3.12e-05	0.000257	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.11e-05	0.000256	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA2—liver cancer	3.04e-05	0.00025	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.99e-05	0.000246	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTA1—liver cancer	2.93e-05	0.000242	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.93e-05	0.000242	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.9e-05	0.00024	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HPGDS—liver cancer	2.9e-05	0.000239	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NAT2—liver cancer	2.9e-05	0.000239	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.88e-05	0.000238	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CPT1B—liver cancer	2.87e-05	0.000237	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GLUL—liver cancer	2.87e-05	0.000237	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDOB—liver cancer	2.78e-05	0.000229	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NR1H4—liver cancer	2.77e-05	0.000228	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA3—liver cancer	2.72e-05	0.000224	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.67e-05	0.00022	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CRABP1—liver cancer	2.65e-05	0.000219	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.65e-05	0.000218	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.63e-05	0.000217	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.59e-05	0.000214	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMA4—liver cancer	2.58e-05	0.000213	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMD10—liver cancer	2.58e-05	0.000213	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.58e-05	0.000213	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GOT2—liver cancer	2.51e-05	0.000207	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA4—liver cancer	2.49e-05	0.000205	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.43e-05	0.000201	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA2—liver cancer	2.42e-05	0.0002	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2E1—liver cancer	2.36e-05	0.000195	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA1—liver cancer	2.34e-05	0.000193	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HPGDS—liver cancer	2.32e-05	0.000191	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NAT2—liver cancer	2.31e-05	0.000191	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.29e-05	0.000189	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.22e-05	0.000183	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDOB—liver cancer	2.22e-05	0.000183	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GLUL—liver cancer	2.21e-05	0.000183	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CPT1B—liver cancer	2.21e-05	0.000183	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYCS—liver cancer	2.21e-05	0.000182	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.18e-05	0.00018	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GOT1—liver cancer	2.17e-05	0.000179	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GGT1—liver cancer	2.17e-05	0.000179	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NR1H4—liver cancer	2.14e-05	0.000176	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CRABP1—liver cancer	2.12e-05	0.000174	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA3—liver cancer	2.1e-05	0.000173	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMA4—liver cancer	2.06e-05	0.00017	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMD10—liver cancer	2.06e-05	0.00017	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GOT2—liver cancer	2.01e-05	0.000166	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.97e-05	0.000162	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—liver cancer	1.95e-05	0.000161	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—liver cancer	1.92e-05	0.000159	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA4—liver cancer	1.92e-05	0.000158	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.9e-05	0.000157	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2E1—liver cancer	1.89e-05	0.000156	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA2—liver cancer	1.87e-05	0.000154	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HPGDS—liver cancer	1.85e-05	0.000152	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.84e-05	0.000152	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA1—liver cancer	1.81e-05	0.000149	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—liver cancer	1.79e-05	0.000148	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NAT2—liver cancer	1.78e-05	0.000147	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.78e-05	0.000147	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYCS—liver cancer	1.77e-05	0.000146	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GOT1—liver cancer	1.73e-05	0.000143	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GGT1—liver cancer	1.73e-05	0.000143	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDOB—liver cancer	1.71e-05	0.000141	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.67e-05	0.000138	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.65e-05	0.000136	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMA4—liver cancer	1.65e-05	0.000136	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMD10—liver cancer	1.65e-05	0.000136	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CRABP1—liver cancer	1.63e-05	0.000135	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GOT2—liver cancer	1.6e-05	0.000132	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—liver cancer	1.58e-05	0.000131	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—liver cancer	1.56e-05	0.000128	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARA—liver cancer	1.55e-05	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—liver cancer	1.54e-05	0.000127	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2E1—liver cancer	1.51e-05	0.000124	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.46e-05	0.00012	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—liver cancer	1.43e-05	0.000118	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HPGDS—liver cancer	1.43e-05	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYCS—liver cancer	1.41e-05	0.000116	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.4e-05	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GGT1—liver cancer	1.38e-05	0.000114	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GOT1—liver cancer	1.38e-05	0.000114	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—liver cancer	1.36e-05	0.000112	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—liver cancer	1.33e-05	0.00011	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—liver cancer	1.28e-05	0.000106	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMD10—liver cancer	1.27e-05	0.000105	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMA4—liver cancer	1.27e-05	0.000105	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—liver cancer	1.26e-05	0.000104	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—liver cancer	1.24e-05	0.000103	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARA—liver cancer	1.24e-05	0.000102	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GOT2—liver cancer	1.24e-05	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—liver cancer	1.23e-05	0.000101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—liver cancer	1.17e-05	9.65e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2E1—liver cancer	1.16e-05	9.59e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—liver cancer	1.15e-05	9.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—liver cancer	1.14e-05	9.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYCS—liver cancer	1.09e-05	8.98e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—liver cancer	1.08e-05	8.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GOT1—liver cancer	1.07e-05	8.81e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GGT1—liver cancer	1.07e-05	8.81e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—liver cancer	1.06e-05	8.76e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—liver cancer	1.03e-05	8.46e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—liver cancer	1.02e-05	8.41e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—liver cancer	1.01e-05	8.33e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARA—liver cancer	9.9e-06	8.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—liver cancer	9.59e-06	7.91e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—liver cancer	9.46e-06	7.8e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—liver cancer	9.34e-06	7.7e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—liver cancer	9.22e-06	7.6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.9e-06	7.34e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—liver cancer	8.82e-06	7.27e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—liver cancer	8.48e-06	7e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—liver cancer	8.36e-06	6.89e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—liver cancer	8.19e-06	6.75e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—liver cancer	8.14e-06	6.71e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—liver cancer	7.79e-06	6.43e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARA—liver cancer	7.64e-06	6.3e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—liver cancer	7.46e-06	6.15e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—liver cancer	7.36e-06	6.07e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—liver cancer	6.55e-06	5.4e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—liver cancer	6.5e-06	5.36e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—liver cancer	6.32e-06	5.21e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—liver cancer	6.21e-06	5.12e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—liver cancer	5.75e-06	4.75e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—liver cancer	5.68e-06	4.69e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—liver cancer	5.08e-06	4.19e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—liver cancer	5.02e-06	4.14e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—liver cancer	4.96e-06	4.09e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—liver cancer	4.05e-06	3.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—liver cancer	3.96e-06	3.27e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—liver cancer	3.24e-06	2.67e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—liver cancer	3.06e-06	2.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—liver cancer	2.5e-06	2.06e-05	CbGpPWpGaD
